Furthermore, our validation results suggested that the loss of four mTOR-related genes (PTEN, FLCN, RRAGC, and RPS6KA1) was associated with enhanced long-term proliferation and target tumor cell killing (Figure 3G). Here, RRAGC is linked to neoplasm.